Section 6: The Company Stock 6a: General Stock Information Learning Objective: Identify basic equity information about the company. Most of this information is on the face of your balance sheet and some on the cover of the 10-k. 6a: General Stock Information What type of stock is issued according to the company's balance sheet? Were any dividends issued this year? Where did you find this information? What is the par value of the common stock? How many shares of common stock were issued as of the end of the current year? Where, specifically, did you find this information? Does the company currently hold any treasury stock? Where, specifically, did you find this information? JOHNSON & JOHNSON AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS At January 3, 2021 and December 29, 2019 (Dollars in Millions Except Share and Per Share Amounts) (Note 1) 2020 2019 $ 13,985 11.200 13.576 9,344 3.132 51,237 18.766 3.402 36,393 8.534 6,562 174,894 17.305 1.982 14.481 9,020 2,392 94 45.274 17,658 47.643 33.639 7,819 5,699 157,728 $ Assets Current assets Cash and cash equivalents (Notes 1 and 2) Marketable securities (Notes 1 and 2) Accounts receivable trade, less allowances for doubtful accounts $293 (2019.5226) Inventories (Notes 1 and 3) Prepaid expenses and other receivables Assets held for sale (Note 18) Total current assets Property, plant and equipment, net (Notes 1 and 4) Intangible assets, net (Notes 1 and 5) Goodwill (Notes 1 and 5) Deferred taxes on income (Note 8) Other assets Total assets Liabilities and Shareholders' Equity Current liabilities Loans and notes payable (Note 7) Accounts payable Accrued liabilities Accrued rebates, returns and promotions Accrued compensation and employee related obligations Accrued taxes on income (Note 8) Total current liabilities Long-term debt (Note 7) Deferred taxes on income (Note 8) Employee related obligations (Notes 9 and 10) Long-term taxes payable (Note 1) Other liabilities Total liabilities Commitments and Contingencies (Note 19) Shareholders' equity Preferred stock without par value (authorized and unissued 2,000,000 shares) Common stock - par value S1.00 per share (Note 12) (authorized 4.320,000,000 shares, issued 3.119.843,000 shares) Accumulated other comprehensive income (loss) (Note 13) Hetained earnings 2.631 9.505 13,968 11.513 3,484 1.392 42,493 32,635 7,214 10,771 6,559 11.944 111,616 1,202 8.544 9,715 10.883 1354 2,266 35.964 26.494 5.958 10,663 7.444 11.734 98,257 Less: common stock held in treasury, al cost (Notc 12) (487,331,000 shares and 487,336,000 shares) Total shareholders' equity Total liabilities and shareholders' equity 3,120 (15.242) 113.890 101,768 38,490 63,278 174,894 3,120 (15.891) 110.639 97.888 38,417 59,471 157,728 See Notes to Consolidated Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 3, 2021 D or Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number 1-3215 22-1024240 (RS. Employer identification No JOHNSON & JOHNSON (Exact name of registrant specified in is channe) New Jersey State of incorporation) One Johnson & Johnson Plaza New Brunswick, New Jersey (Address of principal executive offices) One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 (Address of principal executive offices) 08933 (Zip Codle Registrant's telephone number, including area code: (732) 524 0400 SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Tide of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $1.00 JN New York Stock Exchange 0.250% Notes Due January 2022 JNJ22 New York Stock Exchange 0.650W Notes Due May 2024 IN/24C New York Stock Exchange 5.50 Notes Du November 2024 JNI24BP New York Stock Exchange 1.150W Notes Due November 2028 JNI28 New York Stock Exchange 1.650X Notes Due May 2035 JNI35 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No O Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No ca Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (ar for such shorter period that the registrant was required 10 file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of large accelerated filer," "accelerated filer" "smaller reporting company," and "emerging growth company in Rule 125-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company JOHNSON & JOHNSON FORM 10-K (Annual Report) Filed 02/22/21 for the Period Ending 01/03/21 Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK, NJ, 08933 Telephone 732-524-2455 CIK 0000200406 Symbol JNJ SIC Code 2834 - Pharmaceutical Preparations Industry Pharmaceuticals Sector Healthcare Fiscal Year 01/02